Unlimited Bio
PrivateLast Round
Strategic
Oct 22, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Unlimited Bio operates in Healthcare & Life Sciences and is based in Honduras. Its latest recorded funding round was a Strategic round in October 2025.
Unlimited Bio is a biotechnology company that develops combinatorial gene therapies and rejuvenation interventions designed to address the systemic processes of aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Unlimited Bio Comparables
Compare Unlimited Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Minicircle | 91% | |
| GARM Clinic | 84% | |
| Libella Gene Therapeutics | 80% |
For institutional investors. Book with your work email.
Unlimited Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 22, 2025 | ||||
| Seed | Apr 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Unlimited Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Infinita Fund | Seed |
| Immortal Dragons | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 128% MoM, reaching 1.9K.
- May 17, 2026
Monthly visitors increased 308% MoM.
For institutional investors. Book with your work email.
Unlimited Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Unlimited Bio's valuation, stock price, and market status.
Is Unlimited Bio a public or private company?
Unlimited Bio is a private company.
What is the current stock price of Unlimited Bio?
Unlimited Bio is a private company, so its shares have no public market price. Caplight tracks Unlimited Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Unlimited Bio worth (valuation)?
Valuation information for Unlimited Bio is not publicly available.
Can I buy Unlimited Bio stock?
Unlimited Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Unlimited Bio's last funding round?
Unlimited Bio's most recent funding round was Strategic on October 22, 2025.
Who are the main investors in Unlimited Bio?
Key investors in Unlimited Bio include Immortal Dragons.
Will Unlimited Bio IPO soon?
No public IPO plans have been announced for Unlimited Bio.
How can I track Unlimited Bio secondary market activity?
Caplight tracks bids, offers, and trades in Unlimited Bio's shares on secondary markets.